|
VIVK Vivakor, Inc.
Vivakor Announces Receipt of LOI for $600k Investment
.Companies:Vivakor, Inc..Press Release Source: Vivakor, Inc. On Friday June 4, 2010, 4:30 pm EDT
CORALVILLE, Iowa, June 4, 2010 (GLOBE NEWSWIRE) -- Vivakor, Inc. (OTCBB:VIVK - News) today announced that the Company has received a letter of intent for an investment up to $600,000 from Excelsior Management. The terms of the transaction are for an investment in restricted common stock at $0.08 per share or shares registered in the current S-1 at the S-1 price of $0.23 per share.
Vivakor Chairman Matt Nicosia added this statement to the news: "This investment interest in Vivakor coincides with management's belief that the Company is currently undervalued and validates management's efforts to create value by reducing debt and increasing the viability of its technologies. We look forward to increasing the Company's value through pushing forward commercialization efforts for both VIVASLICES and VIVASIGHT."
About Vivakor, Inc.
Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at .
|